Mandate

Vinge represents Gambro in the sale of Gambro Healthcare

May 10, 2007

Vinge is representing Gambro in the sale of Gambro Healthcare to Bridgepoint. The sale of Gambro Healthcare was a part of the plan that was implemented when Investor and EQT acquired Gambro in June 2006. The sale requires the approval of the EU Commission before it can be concluded.
 
The partner in charge is Fredrik von Baumgarten, who is assisted by associates Tuula Tallavaara, Ulrich Ziche, Marion Ehman and Martin Hall. For financial matters, Gambro is represented by Fabian Ekeblad, together with Ann Bokinge and Hanna Fanning.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026